3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
62
Glioblastoma
52
Lung Neoplasms
49
Breast Neoplasms
46
Prostatic Neoplasms
39
Head and Neck Neoplasms
38
Squamous Cell Carcinoma of Head and Neck
33
Esophageal Neoplasms
30
Brain Neoplasms
28
Lymphoma
27
Gliosarcoma
27
Rectal Neoplasms
24
Hodgkin Disease
24
Pancreatic Neoplasms
22
Adenocarcinoma Of Esophagus
22
Central Nervous System Neoplasms
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Neoplasms
20
Lymphoma, Non-Hodgkin
17
Leukemia
17
Glioma
17
Burkitt Lymphoma
16
Sarcoma
15
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma, Follicular
14
Carcinoma, Squamous Cell
14
Colorectal Neoplasms
13
Astrocytoma
13
Neoplasm Metastasis
12
Melanoma
12
Interventions
blinatumomab
4
Rituximab
4
Cyclophosphamide
3
ponatinib
2
Vorinostat
2
Vincristine
2
Prednisone
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bortezomib
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
durvalumab
1
cobomarsen
1
asparaginase erwinia chrysanthemi recombinant
1
acalabrutinib
1
Methotrexate
1
Melphalan
1
Lutetium
1
Lenalidomide
1
KW-2478
1
Imatinib Mesylate
1
Hsp90 inhibitor KU757
1
Dexamethasone
1
Daunorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoproliferative Disorders
×
Radiotherapy
×
Clear all
No trials found.